Category: Alzheimer's Disease
Global Alzheimer's Disease
-
Global Acetylcholinesterase Inhibitors Market - 2024-2031
... forecast period 2024-2031. Acetylcholinesterase inhibitors (AChEIs) are a specific kind of drug that is essential in the treatment of a variety of neurological illnesses, including Alzheimer's disease and other forms of dementia. These medications work ... Read More
-
Citicoline Market Research Report Information by Product (Capsules, Tablets, Powder, Eye Drops, and Injection) by Application (Sports Nutrition, Personal Wellness, Treatment [Glaucoma, Stroke, Alzheimer disease, Channel (pression, and Others]), by Age Group (Pediatric, Adult, and Geriatric) by Distribution Channel (Online Channel, Offline Channel), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... Geriatric) by Distribution Channel (Online Channel, Offline Channel), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032 The Citicoline market was valued at USD 0.43 billion in 2023 and ... Read More
-
Global Targeted Drugs for Alzheimer's Disease Market Growth (Status and Outlook) 2024-2030
... it is expected to grow at a CAGR of %from 2024 to 2030. LPI (LP Information)' newest research report, the “Targeted Drugs for Alzheimer's Disease Industry Forecast” looks at past sales and reviews total world ... Read More
-
Alzheimers Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 3.52 billion in 2022, and the market is now projected to grow from USD 3.69 billion in 2023 to USD 5.21 billion by 2030, exhibiting a CAGR of 5.1% during the forecast period of 2023-2030. ... Read More
-
Precision Psychiatry Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global precision psychiatry market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global precision ... Read More
-
Global Alzheimer's Treatment Drug Market Growth 2024-2030
... the Alzheimer's Treatment Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Alzheimer's Treatment ... Read More
-
Global Alzheimer's Disease Diagnostic Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various market segments, while the ... Read More
-
Global Alzheimer's Disease Therapeutics and Diagnostics Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... provides a comprehensive overview by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various ... Read More
-
Global Blood Tests for Alzheimer's Diagnosis Market Growth (Status and Outlook) 2024-2030
... identify biomarkers associated with Alzheimer's, such as amyloid-beta and tau proteins, which are indicators of the characteristic plaques and tangles in the brain. Advances in technology have made it possible to measure these proteins with ... Read More
-
Global Alzheimer's Blood Tests Market Growth (Status and Outlook) 2024-2030
... beta-amyloid and tau, which are hallmarks of the disease, as well as other indicators of neural damage and inflammation. The development of these tests offers a less invasive and potentially more accessible alternative to traditional ... Read More
-
Alzheimer's Drugs – A Global Market Overview
... 65 and older. It is defined by memory loss, cognitive decline, and the formation of plaques and tangles in the brain that interrupt neuron communication. Alzheimer's disease advances in phases, ranging from mild cognitive impairment ... Read More
-
Global Early Diagnosis Kit For Alzheimer's Disease Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... memory loss. It is the most common cause of dementia, a syndrome characterized by a decline in cognitive function that interferes with daily life. Alzheimer's disease is named after Dr. Alois Alzheimer, who first identified ... Read More
-
Global Alzheimer's Disease Therapeutics and Diagnostics Market Research Report 2024(Status and Outlook)
... time. It is the cause of 60% to 70% of cases of dementia. The Global Alzheimer's Disease Therapeutics and Diagnostics Market Size was estimated at USD 3688.12 million in 2023 and is projected to reach ... Read More
-
Global Alzheimer's Disease Diagnostic Market Research Report 2024(Status and Outlook)
... is the cause of 60% to 70% of cases of dementia. The Global Alzheimer's Disease Diagnostic Market Size was estimated at USD 3688.12 million in 2023 and is projected to reach USD 4032.75 million by ... Read More
-
Global Alzheimer's Disease Treatments Market Research Report 2024(Status and Outlook)
... is the cause of 60% to 70% of cases of dementia. The Global Alzheimer's Disease Treatments Market Size was estimated at USD 3688.12 million in 2023 and is projected to reach USD 4032.75 million by ... Read More
-
Global Alzheimer's Disease Drug Market Research Report 2024(Status and Outlook)
... is the cause of 60% to 70% of cases of dementia. The Global Alzheimer's Disease Drug Market Size was estimated at USD 3684.64 million in 2023 and is projected to reach USD 4028.94 million by ... Read More
-
Blood Brain Barrier Market (3rd Edition): Industry Trends and Global Forecasts, till 2035
... period 2024-2035. The focus of blood-brain barrier drugs and technologies is to address the challenges posed by the selective nature of the blood-brain barrier, enabling therapeutic agents to reach the brain directly. Recent years have ... Read More
-
Global Alzheimer's Disease Market Growth (Status and Outlook) 2024-2030
... downstream market, the Alzheimer's Disease is forecast to a readjusted size of US$ 3943.3 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global ... Read More
-
Mild Cognitive Impairment Market Research Report By Disease Type (Amnestic MCI and Non-Amnestic MCI), By Age (Child, Adult, Geriatric), By Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others) By Treatment (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – Industry Forecast Till 2032
... (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – ... Read More
-
Global Alzheimer's Disease Blood Diagnostic Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... in the blood to identify and diagnose Alzheimer's Disease. These diagnostics aim to detect the presence of pathological changes associated with AD, such as amyloid plaques, tau tangles, neurodegeneration, and other related abnormalities, using minimally ... Read More
-
Dementia Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global dementia drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global dementia ... Read More
-
Neurological Biomarkers Market Report by Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers, and Others), Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), End Use (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, and Others), and Region 2024-2032
... Research Organizations, and Others), and Region 2024-2032 The global neurological biomarkers market size reached US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.0 Billion by 2032, exhibiting a ... Read More
-
GLP-1 Market: Industry Trends and Global Forecasts, till 2035
... Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist and Short-acting GLP-1 Agonist), Type of Agonist (Single-agonist, Dual-agonist and Tri-agonist) Route of Administration (Oral and Parenteral), Target indication (Alzheimer’s Disease, ... Read More
-
Global Digital Brain Health Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Region, and Segment Forecasts, 2023 – 2032 Global Digital Brain Health market was valued at US $198.1 Billion in 2022 and is expected to reach ~US $400 Billion by 2032, growing at a CAGR of ... Read More
-
Neurodegenerative Drugs
... at a CAGR of 4.2% over the analysis period 2023-2030. Multiple Sclerosis Drugs, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$38.3 Billion by the end ... Read More
Research Assistance
